ArticleFrontiers in medicine2022

Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells.

Katarina Tripska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.